Clinical Trial Update: Treatment Protocol of Children With Philadelphia Chromosome Negative High Risk Acute Lymphoblastic Leukemia [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update describing a treatment protocol for children with Philadelphia chromosome-negative high-risk acute lymphoblastic leukemia.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Lymphoblastic Leukemia
• Philadelphia Chromosome-negative Acute Lymphoblastic Leukemia

Snippet

Sponsor: Chinese Academy of Medical Sciences | Conditions: Childhood Acute Lymphoblastic Leukemia, Philadelphia Chromosome, Ph^1^, Absent | Phase 4 | Status: UNKNOWN